Nova Labs Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NOVA LABS LTD
NOVA LABS LTD has two approved drugs.
There is one US patent protecting NOVA LABS LTD drugs.
There are seven patent family members on NOVA LABS LTD drugs in seven countries.
Summary for Nova Labs Ltd
| International Patents: | 7 |
| US Patents: | 1 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Nova Labs Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nova Labs Ltd | XROMI | hydroxyurea | SOLUTION;ORAL | 216593-001 | Apr 4, 2024 | RX | Yes | Yes | 12,409,156 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Nova Labs Ltd | XROMI | hydroxyurea | SOLUTION;ORAL | 216593-001 | Apr 4, 2024 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Nova Labs Ltd | PURIXAN | mercaptopurine | SUSPENSION;ORAL | 205919-001 | Apr 28, 2014 | AB | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Nova Labs Ltd Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Portugal | 3644967 | ⤷ Start Trial |
| Finland | 3644967 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2019220134 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
